American Assets Inc Q2 2026 Portfolio Changes: Significant Increase in ARS PHARMACEUTICALS INC (SPRY) and Reductions
American Assets Inc reported notable changes to its portfolio holdings during the second quarter of 2026, including a substantial increase in shares of ARS PHARMACEUTICALS INC (SPRY) and significant reductions across several stocks.
For the period ending June 30, 2026, American Assets Inc (AAI) has disclosed specific changes to its investment portfolio. The firm's holdings have seen significant shifts this quarter.
Major Increase in ARS PHARMACEUTICALS INC (SPRY)
American Assets Inc (AAI) demonstrated a strong buying interest by significantly increasing its position in ARS PHARMACEUTICALS INC (SPRY). According to the filing, this healthcare stock saw an increase of 118,000 shares during Q2 2026. This substantial growth represents a portfolio weight percentage change and highlights that ARS PHARMACEUTICALS INC is now one of the investor's significant holdings.
Significant Reductions: Capital One (COF) and Amazon (AMZN)
The investment landscape for American Assets Inc (AAI) also featured notable selling activity. The firm significantly reduced its stake in CAPITAL ONE FINL CORP (COF), cutting holdings by 20,000 shares (-66.67% change). Similarly, the investor drastically decreased its position in consumer cyclical stock AMAZON COM INC (AMZN), reducing shares by 73,000 (-97.33%). These actions indicate a major shift away from these two previously significant holdings.
Other Changes and Portfolio Context
Beyond the headline-grabbing moves in SPRY, COF, and AMZN, American Assets Inc (AAI) also reported changes in other stocks. The investor maintained its positions in major holdings like AMERICAN ASSETS TR INC (AAT) and WELLS FARGO & CO (WFC), which remained unchanged from the previous period. Other changes, such as minor adjustments in holdings of TRUIST FINL CORP (TFC) and exits like from CHEVRON CORPORATION, are detailed in the full filing.
The portfolio's overall value stood at $332,288,362 as of June 30, 2026. The changes reflect a strategic rebalancing focused on healthcare and away from consumer cyclical stocks like Amazon. Further analysis would be needed to understand the full impact of these shifts within their broader investment strategy.
Conclusion: Strategic Shifts in Q2 Portfolio
In summary, American Assets Inc (AAI)' portfolio actions during the second quarter of 2026 were characterized by a large purchase and two significant sales. The substantial increase in ARS PHARMACEUTICALS INC (SPRY) suggests confidence or alignment with healthcare sector performance, while the sharp declines in CAPITAL ONE FINL CORP (COF) and AMAZON COM INC (AMZN) indicate a deliberate reduction in exposure to these areas. Investors should monitor the performance of these changed holdings, particularly the newly increased position in SPRY, as they impact AAI's overall portfolio allocation and value.